Cantharidin Application in Patients With Common Warts (Verruca Vulgaris) (COVE-3)
Public ClinicalTrials.gov record NCT07637734. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
COVE-3: A Phase 3, Double-blind, Randomized, Vehicle-controlled Study to Evaluate the Efficacy and Safety of YCANTH (VP-102/TO-208) in Subjects With Common Warts (Verruca Vulgaris)
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 3, double-blind, randomized, vehicle-controlled study (Study number VP-CW-302; referred to as COVE-3 \[Cantharidin and Occlusion in Verruca Epithelium\]) to evaluate the efficacy and safety of YCANTH (VP-102/TO-208) treatment in subjects with common warts.
Study identification
- NCT ID
- NCT07637734
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 300 participants
Conditions and interventions
Interventions
- VP-102 (US) / TO-208 (Japan) Combination Product
- Vehicle (US) / Vehicle (Japan) Combination Product
Combination Product
Eligibility (public fields only)
- Age range
- 2 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 15, 2026 (Actual)
- Primary completion
- May 2027 (Estimated)
- Completion
- Jul 2027 (Estimated)
- Last update posted
- Sep 3, 2026
2026 – 2027
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| West Dermatology Research Center | San Diego | California | 92121 | Not yet recruiting |
| APEX Clinical Trials | Jacksonville | Florida | 32256 | Recruiting |
| LENUS Research & Medical Group, LLC | Sweetwater | Florida | 33172 | Recruiting |
| Research Institute of the Southeast, LLC | West Palm Beach | Florida | 33401 | Recruiting |
| Endeavor Health | Skokie | Illinois | 60077 | Not yet recruiting |
| DelRicht Research | Overland Park | Kansas | 66209 | Active, not recruiting |
| DelRicht Research | Baton Rouge | Louisiana | 70809 | Active, not recruiting |
| MetroBoston Clinical Partners | Brighton | Massachusetts | 02135 | Recruiting |
| Minnesota Clinical Study Center | New Brighton | Minnesota | 55112 | Recruiting |
| Midwest Children's Health Research Institute | Lincoln | Nebraska | 68516 | Not yet recruiting |
| UNMC - Children's Hospital & Medical Center | Omaha | Nebraska | 68114 | Not yet recruiting |
| Austin Institute for Clinical Research | Pflugerville | Texas | 78660 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07637734, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 3, 2026 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07637734 live on ClinicalTrials.gov.